Literature DB >> 16817242

Binding capacity differences for antibodies and Fc-fusion proteins on protein A chromatographic materials.

Sanchayita Ghose1, Brian Hubbard, Steven M Cramer.   

Abstract

A range of studies were carried out to investigate the underlying reason for differences in dynamic binding capacities observed with various antibodies and Fc-fusion proteins during Protein A chromatography. Dynamic binding capacities were determined for these biomolecules using different protein A stationary phase materials. SEC was carried out to determine the relative sizes of the antibodies and fusion proteins. Pore diffusivities and static binding capacities were also determined on these Protein A resin materials. Trends in the dynamic binding capacities for these molecules did not correlate with differences in pore diffusion coefficients as might be expected for a mass transfer limited system. Instead, dynamic binding capacities were seen to follow the same trends as the static binding capacities and the apparent size of the molecules. Differences in static binding capacities were attributed to be due to differences in steric factor between the molecules. Solution binding stoichiometry studies were employed to estimate intra-Protein A steric effects while binding to the various domains within a Protein A ligand. In addition, steric hindrance was also found to exist between adjacent immobilized Protein A ligands on the chromatographic surface. The combination of intra and inter Protein A steric hindrances can explain differences in binding capacities observed between various antibody and Fc fusion proteins. The effect of Protein A ligand density on these supports was also examined and the results indicate that increasing Protein A ligand density leads to a situation of diminishing returns for binding capacity due to increased steric hindrance on the resin surface. The results presented in this paper show that steric hindrances can dominate over mass transfer effects in causing capacity variation between different molecules on the same stationary phase. This can lead to the development of more cost-efficient chromatographic stationary phases as well as provide information during the selection of Protein A media for preparative purification of monoclonal antibodies and Fc fusion proteins.

Mesh:

Substances:

Year:  2007        PMID: 16817242     DOI: 10.1002/bit.21044

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  17 in total

Review 1.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Immobilization of Bioactive Protein A from Staphylococcus aureus (SpA) on the Surface of Bacillus subtilis Spores.

Authors:  Samira Ghaedmohammadi; Garshasb Rigi; Reza Zadmard; Ezio Ricca; Gholamreza Ahmadian
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

3.  Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.

Authors:  Michael Logan; John Law; Jason Alexander Ji-Xhin Wong; Darren Hockman; Amir Landi; Chao Chen; Kevin Crawford; Juthika Kundu; Lesley Baldwin; Janelle Johnson; Anita Dahiya; Gerald LaChance; Joseph Marcotrigiano; Mansun Law; Steven Foung; Lorne Tyrrell; Michael Houghton
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab.

Authors:  Parisa Yousefpour; Fatemeh Atyabi; Ebrahim Vasheghani-Farahani; Ali-Akbar Mousavi Movahedi; Rassoul Dinarvand
Journal:  Int J Nanomedicine       Date:  2011-09-14

5.  Evaluation of a novel methacrylate-based Protein A resin for the purification of immunoglobulins and Fc-fusion proteins.

Authors:  Tyler R McCaw; Edward K Koepf; Lynn Conley
Journal:  Biotechnol Prog       Date:  2014-07-24

6.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

7.  Improved Performance of Recombinant Protein A Immobilized on Agarose Beads by Site-Specific Conjugation.

Authors:  Xufeng Zhang; Ya Duan; Xi Zeng
Journal:  ACS Omega       Date:  2017-04-28

8.  Increasing immunoglobulin G adsorption in dextran-grafted protein A gels.

Authors:  Liming Huan; Qing-Hong Shi
Journal:  Eng Life Sci       Date:  2021-03-20       Impact factor: 2.678

9.  Targeting the vasculature of colorectal carcinoma with a fused protein of (RGD)₃-tTF.

Authors:  Zheng-jie Huang; Yilin Zhao; Wei-yuan Luo; Jun You; Shui-wen Li; Wen-cheng Yi; Sheng-yu Wang; Jiang-hua Yan; Qi Luo
Journal:  ScientificWorldJournal       Date:  2013-06-18

10.  Quality by design approach for viral clearance by protein a chromatography.

Authors:  Min Zhang; George R Miesegaes; Michael Lee; Daniel Coleman; Bin Yang; Melody Trexler-Schmidt; Lenore Norling; Philip Lester; Kurt A Brorson; Qi Chen
Journal:  Biotechnol Bioeng       Date:  2013-08-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.